Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3876122rdf:typepubmed:Citationlld:pubmed
pubmed-article:3876122lifeskim:mentionsumls-concept:C0042971lld:lifeskim
pubmed-article:3876122lifeskim:mentionsumls-concept:C1264039lld:lifeskim
pubmed-article:3876122lifeskim:mentionsumls-concept:C0205161lld:lifeskim
pubmed-article:3876122lifeskim:mentionsumls-concept:C0019409lld:lifeskim
pubmed-article:3876122lifeskim:mentionsumls-concept:C1515021lld:lifeskim
pubmed-article:3876122lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3876122pubmed:issue4lld:pubmed
pubmed-article:3876122pubmed:dateCreated1985-10-31lld:pubmed
pubmed-article:3876122pubmed:abstractTextType I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS)-agarose gel electrophoresis. For 17 patients (13 kindreds) diagnosed with these criteria, we have studied the platelet contents of vWF:Ag and RiCof and the changes of these in plasma after DDAVP infusion. Platelet vWF:Ag and RiCof were normal in four kindreds (called "platelet normal" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF:Ag, RiCof and the bleeding time (BT) became normal. In six kindreds, platelet vWF:Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF:Ag and RiCof remained low, and the BT was prolonged. In three additional kindreds, platelets contained normal concentrations of vWF:Ag, but RiCof was very low (platelet discordant); even though a complete set of multimers was found in plasma and platelets, there was a relatively small amount of large multimers. After DDAVP, plasma vWF:Ag became normal, but RiCof remained low and the BT was very prolonged. These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF:Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF:Ag and RiCof (platelet normal).lld:pubmed
pubmed-article:3876122pubmed:languageenglld:pubmed
pubmed-article:3876122pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876122pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3876122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876122pubmed:statusMEDLINElld:pubmed
pubmed-article:3876122pubmed:monthOctlld:pubmed
pubmed-article:3876122pubmed:issn0006-4971lld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:LombardiRRlld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:MannucciP MPMlld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:BadeaAAlld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:MazzucconiM...lld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:MarianiGGlld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:SolinasSSlld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:FedericiA BABlld:pubmed
pubmed-article:3876122pubmed:authorpubmed-author:VianelloLLlld:pubmed
pubmed-article:3876122pubmed:issnTypePrintlld:pubmed
pubmed-article:3876122pubmed:volume66lld:pubmed
pubmed-article:3876122pubmed:ownerNLMlld:pubmed
pubmed-article:3876122pubmed:authorsCompleteYlld:pubmed
pubmed-article:3876122pubmed:pagination796-802lld:pubmed
pubmed-article:3876122pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:meshHeadingpubmed-meshheading:3876122-...lld:pubmed
pubmed-article:3876122pubmed:year1985lld:pubmed
pubmed-article:3876122pubmed:articleTitleHeterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.lld:pubmed
pubmed-article:3876122pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3876122pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876122lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876122lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876122lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876122lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876122lld:pubmed